The price of Xcopri, an anti-seizure medication, can vary significantly depending on factors such as insurance coverage, pharmacy, and prescribed dosage. Patients often explore options to manage the cost.
What is the typical out-of-pocket cost for Xcopri?
Without insurance, a month's supply of Xcopri can cost several thousand dollars. For instance, one source indicates a price of around $2,700 for 30 tablets of 25 mg [1]. However, with the Xcopri Savings Card program, eligible commercially insured patients may pay as little as $10 per prescription, with a maximum monthly savings of $300 [1]. This program has specific terms and conditions, including income limitations and the requirement that the drug not be covered by a government healthcare program.
How can I get financial assistance for Xcopri?
Beyond the Xcopri Savings Card, other avenues for financial assistance exist. The manufacturer may offer patient assistance programs for uninsured or underinsured individuals who meet certain eligibility criteria. Additionally, some non-profit organizations and foundations provide grants or co-pay assistance for epilepsy and seizure disorder medications. Exploring these options can significantly reduce the financial burden for patients.
When does Xcopri's patent expire?
Understanding patent expiration is crucial for anticipating potential price changes or the introduction of generic alternatives. According to DrugPatentWatch.com, information regarding Xcopri's patent expiration dates is available on their platform [2]. Patent details and exclusivity periods often dictate market exclusivity and influence pricing strategies.
Who manufactures Xcopri?
Xcopri (cenobamate) is manufactured by SK Life Science, Inc. [1]. Knowing the manufacturer can be helpful when seeking information about patient assistance programs or reporting adverse events.